Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

Go to Regulatory Recap News

Subscribe for Weekly Updates

The Advocacy &  Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.

Subscribe

Billing & Payments

Kentucky Considers New Billing and Payment Deadlines

Timelines for bill submission and payment would begin only after a claim is accepted as compensable.

Read More →

February 24, 2025

Access to Care

Alabama Proposes Workers’ Comp Coverage for Teachers

Currently, public school teachers injured on the job must pay for care out-of-pocket and must request reimbursement.

Read More →

February 24, 2025

Presumptions

West Virginia Proposes Expansion to Firefighter Cancer Presumptions

If passed, House Bill 2197 would extend coverage to bladder cancer, mesothelioma, and testicular cancer.

Read More →

February 17, 2025

Opioids Presumptions

New York Considers Presumption for Opioid Overdose Deaths

The bill would require that deceased workers had received an opioid prescription for their workplace injury.

Read More →

February 17, 2025

Access to Care

New York Could Permit Massage Therapists to Act as Workers’ Comp Providers

If passed, massage therapists could provide care but would not be permitted to establish workplace injury causation or disability.

Read More →

February 17, 2025

Access to Care

Montana Considers Provider Choice Bill for Injured Workers

Provider choice would have to take into account practical matters, such as proximity and the ability to comply with workers’ comp care guidelines.

Read More →

February 17, 2025

Access to Care

Maryland Bills Could Expand Social Worker’s Authority

One bill would allow them to determine mental impairment, while another would let licensed clinical social workers to provide rehabilitation service.

Read More →

February 17, 2025

Mental Health Presumptions

Kentucky Proposes PTSD Presumption

If passed, the presumption would apply to police officers, fire fighters, EMTs, and “frontline staff” which includes other occupations.

Read More →

February 17, 2025

Mental Health Psychedelics

Illinois Introduces Psilocybin Therapy Bill

Along with the supervised therapeutic use, the bill would implement a sales tax, public education, and much more.

Read More →

February 17, 2025

« Previous 1 … 27 28 29 30 31 … 43 Next »

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.

hello world!

Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

COVID-19 Mutations Impact Testing

False negatives may be reported due to genetic variations of the virus.

Worker Classification Debate Continues Across the Country

The Department of Labor issued a new rule while special interest groups push for regulatory change.

The Department of Justice Sues Walmart Over Role in Opioid Crisis

Alleged violations of the Controlled Substances Act could result in billions of dollars in penalties.

Top 10 Disruptors of 2020 for the Workers’ Comp Industry

Initial insights from Healthesystems’ annual industry survey.

FDA Authorizes Two COVID-19 Vaccines, At-Home Test, More Treatments

Vaccine candidates from Pfizer-BioNTech and Moderna received EUAs, as did the first at-home test that delivers results in 30 minutes, and two treatments for the virus.